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Telomere shortening is associated with organismal
aging. iPS cells have been recently derived from old
patients; however, it is not known whether telomere
chromatin acquires the same characteristics as in
ES cells. We show here that telomeres are elongated
in iPS cells compared to the parental differentiated
cells both when using four (Oct3/4, Sox2, Klf4,
cMyc) or three (Oct3/4, Sox2, Klf4) reprogramming
factors and both from young and aged individuals.
We demonstrate genetically that, during reprogram-
ming, telomere elongation is usually mediated by
telomerase and that iPS telomeres acquire the epige-
netic marks of ES cells, including a low density of tri-
methylated histones H3K9 and H4K20 and increased
abundance of telomere transcripts. Finally, reprog-
ramming efficiency of cells derived from increasing
generations of telomerase-deficient mice shows
a dramatic decrease in iPS cell efficiency, a defect
that is restored by telomerase reintroduction.
Together, these results highlight the importance of
telomere biology for iPS cell generation and function-
ality.
INTRODUCTION
Induced pluripotent stem (iPS) cells derived from differentiated
somatic cells represent a new source of stem cells for custom-
ized transplantation therapies (Takahashi and Yamanaka, 2006;
Wernig et al., 2007; Takahashi et al., 2007; Stadtfeld et al., 2008;
Maherali et al., 2007; Okita et al., 2007; Nakagawa et al., 2008;
Aoi et al., 2008). In particular, a combination of a few factors
related to stem cell pluripotency allowed reprogramming of
differentiated mouse and human cells into iPS cells (Takahashi
and Yamanaka, 2006; Wernig et al., 2007; Takahashi et al.,
2007; Stadtfeld et al., 2008; Maherali et al., 2007; Okita et al.,
2007; Nakagawa et al., 2008; Aoi et al., 2008). These factors
include Oct3/4 (also called Pou5f1), Sox2, Klf4, and cMyc; the
latter was found dispensable for iPS cell generation (Nakagawa
et al., 2008). Although full characterization of iPS cells is still in
progress, iPS cells seem to have the same properties as
embryonic stem (ES) cells and share with them a similar global
gene expression pattern, including a correct genome-wide
epigenetic reprogramming (Takahashi and Yamanaka, 2006;
Wernig et al., 2007; Maherali et al., 2007; Mikkelsen et al.,
2008). Furthermore, iPS cells contribute to mouse embryonic
development and to the mouse germline (Takahashi and
Yamanaka, 2006; Wernig et al., 2007; Takahashi et al., 2007;
Stadtfeld et al., 2008; Maherali et al., 2007; Okita et al., 2007;
Nakagawa et al., 2008; Aoi et al., 2008), supporting the notion
that they are pluripotent and indistinguishable from ES cells. In
the case of regenerative transplantation therapies, these find-
ings open the possibility of using iPS cells derived from patients
as a way to bypass the technical difficulties, as well as ethical
controversies, associated with the alternative method of nuclear
transfer to human oocytes, in vitro generation of preimplantation
embryos, and obtention of ES cells.
Telomeres have been shown to shorten associated to
increasing age (Harley et al., 1990) and contribute to organismal
aging by limiting the proliferative capacity of adult stem cells
(Blasco, 2007a; Flores et al., 2005, 2006a). Although telomerase
activity has been found upregulated in both human and mouse
iPS cells (Takahashi et al., 2007; Stadtfeld et al., 2008) and iPS
cells have been recently derived from very old patients (Dimos
et al., 2008), it is not known whether telomeres are re-elongated
and whether telomeric chromatin acquires the same characteris-
tics as in ES cells. For example, telomerase is reactivated in
human cancers; however, the telomeres of most cancer cells
are shorter than those of normal tissues (de Lange et al., 1990;
Meeker et al., 2004).
Telomeres are ribonucleoprotein heterochromatic structures
at the ends of chromosomes that protect them from degradation
and recombination activities (Blackburn, 2001). Telomeres
consist of tandem repeats of the TTAGGG sequence bound to
a 6 protein complex known as shelterin (Blackburn, 2001; de
Lange, 2005). Telomere length is influenced by changes in the
activity of telomerase, the reverse transcriptase that elongates
telomeres (Greider and Blackburn, 1985), as well as by the so-
called alternative lengthening of telomeres or ALT pathway,
which relays in homologous recombination between telomeric
sequences (Dunham et al., 2000). In turn, these telomere-elon-
gating mechanisms are regulated by the epigenetic status of te-
lomeric chromatin (Blasco, 2007b). In particular, both telomeric
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marks characteristic of repressed heterochromatic domains
such as trimethylation of H3K9 and H4K20, and they show
binding of the heterochromatin protein 1 (HP1) (Garcı´a-Cao
et al., 2004; Gonzalo et al., 2006; Benetti et al., 2007). In addition,
the DNA of subtelomeric repeats is heavily methylated (Gonzalo
et al., 2006). Loss of these epigenetic marks results in derepres-
sion of telomere recombination and telomere elongation (Garcı´a-
Cao et al., 2004; Gonzalo et al., 2006; Benetti et al., 2007).
Furthermore, telomeres are transcribed, and the resulting
UUAGGG-rich RNAs (TelRNAs or TERRAs) remain bound to
the telomeric chromatin, where they are proposed to regulate
telomere length (Azzalin et al., 2007; Schoeftner and Blasco,
2008). Telomerase is expressed during embryonic development
and in the stem cell compartment of several adult tissues
(Blasco, 2007a; Flores et al., 2005; 2006a; Liu et al., 2007);
however, telomerase levels in these tissues are not sufficient to
prevent progressive telomere shortening with age both in hu-
mans and mice (Harley et al., 1990; Flores et al., 2008). Reduced
telomerase activity due to mutations in telomerase components
in the human diseases dyskeratosis congenita, aplastic anemia,
and idiopathic pulmonary fibrosis (Mitchell et al., 1999; Yamagu-
chi et al., 2005; Tsakiri et al., 2007; Armanios et al., 2007) further
accelerates telomere shortening and leads to premature loss of
tissue regeneration, suggesting that telomerase levels in the
adult organism are rate limiting and influence organ homeo-
stasis. Further evidence for a role of telomerase and telomere
length in organ homeostasis comes from the study of telome-
rase-deficient mice (Terc/ mice), which show premature aging
and a decreased proliferative potential of adult stem cell popula-
tions (Blasco et al., 1997; Lee et al., 1998; Herrera et al., 1999;
Samper et al., 2002; Ferro´n et al., 2004). Therefore, the function-
ality of iPS cells could be limited in elderly patients or in patients
with a limited telomere reserve, and the resulting iPS cells could
inherit telomeric defects, including suboptimal telomere length.
In this regard, previous studies with cloned animals by means
of somatic cell nuclear transfer into enucleated oocytes have
rendered contradictory results regarding whether telomeres
are elongated or not during nuclear reprogramming (Shiels
et al., 1999; Vogel, 2000; Lanza et al., 2000). On one hand, the
cloned sheep Dolly showed abnormally short telomeres, some-
thing that was attributed to the adult origin of the donor nucleus
(Shiels et al., 1999), whereas cloning of cattle or mice for six
generations had no notable effect on telomere length (Lanza
et al., 2000; Wakayama et al., 2000).
Finally, it is known that, soon after fertilization but previous to
the formation of the blastocyst, telomeres are elongated by
a telomerase-independent recombination-based mechanism
(Liu et al., 2007). This opens several scenarios for the reprogram-
ming of telomeric chromatin, including dispensability of telome-
rase for telomere elongation, cooperation between telomerase-
based and recombination-based mechanisms, and, finally,
complete dependence on telomerase for telomere elongation
during reprogramming.
Here, we show that both telomere length and telomere hetero-
chromatic marks acquire ES cell features during iPS cell gener-
ation. Importantly, we show here that telomeres are also effi-
ciently elongated in iPS cells derived from old animals,
demonstrating that telomeres can be efficiently rejuvenated
during nuclear reprogramming. Interestingly, we show that
telomerase activity is the primary mechanism to mediate telo-
mere re-elongation during reprogramming and that a minimum
telomere length is necessary for iPS cell generation. In particular,
cells derived from telomerase-deficient mice fail to properly
elongate telomeres during reprogramming, and telomeres
continue to shorten during iPS cell generation. Furthermore, an
increasing number of generations of telomerase-deficient mice
with progressive shorter telomeres show a dramatic impairment
in iPS cell generation. These findings highlight the importance of
telomere biology for the generation and proper functionality of
iPS cells.
RESULTS
cMyc IsDispensable for TelomeraseActivation inMouse
iPS Cells
Telomerase activity has been previously shown to increase
during iPS cell generation using a combination of four reprog-
ramming factors (Takahashi et al., 2007; Maherali et al., 2007;
Zhao and Daley, 2008), namely Oct3/4, Sox2, Klf4, and cMyc,
the latter being a transcriptional activator of telomerase in the
mouse (Wu et al., 1999; Flores et al., 2006b). Here, we address
the putative role of cMyc in telomerase activation during mouse
iPS cell generation by comparing telomerase activity levels in
mouse iPS cells generated with four factors (Oct3/4, Sox2,
Klf4, and cMyc; referred to here as 4F iPS cells) with those of
iPS cells generated with three factors in the absence of cMyc
(Oct3/4, Sox2, and Klf4; referred to here as 3F iPS cells) (Naka-
gawa et al., 2008; Wernig et al., 2008). To this end, 3F and 4F
mouse iPS cells were generated from mouse embryonic fibro-
blasts (MEF) as previously described (Takahashi and Yamanaka,
2006; Nakagawa et al., 2008) (Experimental Procedures). The re-
sulting iPS cells showed expression of the endogenous factors
and a similar morphology to ES cells; stained positive for alkaline
phosphatase; maintained the ES cell morphology upon expan-
sion; and expressed the stemness marker Nanog (Figures
S1A–S1E available online). Importantly, both 3F and 4F iPS cells
were able to contribute to mouse embryonic development as
indicated by important mouse chimerism when microinjected
into C57BL6-Tyrc (albino) blastocysts (Figure S1F and Table 1)
or when aggregated with CD1 (albino) morulae (Table 1). In
both cases, around 30% of the pups born were chimeras as
judged by the coat color, with iPS contribution to the coat in
a range of 60%–100% in the case of microinjected blastocysts
and 5%–50% in the case of aggregation to morulae
(Figure S1F and Table 1). Furthermore, both 3F and 4F iPS cells
showed germline transmission (Table 1). These results indicate
that the 3F and 4F wild-type iPS cells generated for this study
are pluripotent and are able to contribute to the mouse germline.
In agreement with this, iPS cells showed a normal chromosomal
ploidy (Figures S2A and S2B).
Telomerase activity was increased 9-fold in 4F iPS cell
clones, compared to the parental MEF, reaching slightly higher
levels than those of control ES cells in the same genetic back-
ground (Figures S3A and S3B) (Takahashi et al., 2007; Maherali
et al., 2007; Zhao and Daley, 2008). A similar 8-fold increase in
telomerase activity was detected in the 3F iPS cells generated
in the absence of the cMyc reprogramming factor (Figures S3A
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Reprogramming of Telomere Chromatin in iPS CellsTable 1. Generation of Chimeras and Germline Transmission with C57BL/6WT iPS Clones Reprogrammedwith Three (3F) or Four (4F)
Factors
Microinjection in B6-tyrC-2J Blastocysts
iPS clone Blastocysts Injected Cells Injected Blastocysts Transferred Pups Born Chimeras Sex (% Pigmentation)
iPS (3F)-7 wt 52 5–8 52 5 1M (100%)a
iPS (3F)-9 wt 43 5–8 43 4 1F (60%)
iPS (4F)-4 wt 58 5–6 58 8 2M (80%)a 1F (100%)
Aggregation with CD1 Morulae
iPS Clone Morulae Aggregated Cells Aggregated Pups Born Chimeras Sex (% Pigmentation)
iPS (4F)-3 wt 171 4–8 15 1M (30%) 1M (5%) 1F (50%) 2F (30%)
3F and 4F WT iPS contribution to the germline
Chimeras 3 B6-tyrC-2J Females
iPS Clone Chimera Sex (% Pigmentation) Black/White Pups
iPS (4F)-4 wt M (80%) 5/14
M (80%) 8/10
iPS (3F)-7 wt M (100%) 11/0
a Germline chimeras.and S3B). These results indicate that cMyc is not essential to up-
regulate telomerase activity during iPS cell generation. In this re-
gard, MEF have high levels of cMyc and may not need additional
cMyc activity to re-express telomerase during iPS cell genera-
tion (Takahashi et al., 2007).
Next, we addressed whether telomerase activation per se was
necessary for efficient iPS cell formation by using cells derived
from first generation (G1) telomerase-deficient Terc/ mice in
a C57BL6 genetic background (Herrera et al., 1999). We were
able to generate iPS cells from G1 telomerase-deficient MEF
to a similar efficiency to wild-type MEF (Figures 2A and 2B), indi-
cating that activation of telomerase per se is not necessary for
iPS cell generation, at least in the presence of a sufficient telo-
mere reserve, such as in the case of G1 Terc/ mice (Herrera
et al., 1999). As expected, telomerase activity was negative
both in parental MEF and in iPS derived from G1 telomerase-
deficient mice (Figures S3A and S3B). Interestingly, in spite of
a normal efficiency of G1 Terc/ iPS cell generation compared
to wild-type controls, we failed to obtain any viable chimeric
mice from these cells. In particular, from a total of 11 pups
born, only one showed a high level of iPS contribution as judged
by eye pigmentation; however, these mice did not survive, in
contrast to a 100% survival in the case of chimeras derived
from wild-type iPS cells (Table 2). These results indicate that
telomerase activity is not limiting for in vitro iPS cell proliferation
when telomeres are sufficiently long, such as in the case of G1
telomerase-deficient iPS cells. However, these cells are severely
impaired in their ability to generate viable mice compared to
wild-type telomerase-proficient 3F and 4F iPS cells, most likely
due to increased chromosomal instability (see Figure 2).
Telomere Elongation by Telomerase in iPS Cells
Next, we addressed whether telomeres were elongated during
the reprogramming of 3F and 4F iPS cells (all at passage 8)
compared to control ES cells by measuring telomere length in
individual clones of these cells using two independent
techniques, Southern telomere restriction analysis (TRF) and
quantitative telomere FISH (Q-FISH) on metaphase spreads
(Experimental Procedures). Telomeres were elongated in wild-
type 4F iPS cells compared to the corresponding parental
wild-type MEF, both as determined by TRF (Figure 1A) and
Q-FISH analyses (Figures 1B–1E). Telomeres were also elon-
gated in 3F iPS cells but did not reach the length of 4F iPS cells
(Figures 1A–1E), although both had similar levels of telomerase
activity (Figures S3A and S3B). Of notice, whereas the freshly
emerged colonies of wild-type 3F and 4F iPS cells have
Table 2. Generation of Chimeras with C57BL/6 G1–G3 Terc/ Mutant iPS Clones
Microinjection in B6-tyrC-2J Blastocysts
iPS Clone MEFs Genotype Blastocysts Injected Cells Injected Blastocysts Transferred Pups Born Chimeras
iPS (3F) 718-7.1 G1 Terc/ 36 5–7 36 10 + 1 dead 1 deada
iPS (3F) 710-8.1 G2 Terc/ 40 5–7 40 11 0
Aggregation with CD1 Morulae
iPS Clone MEFs Genotype Morulae Aggregated Cells Aggregated Embryos Transferred Pups Born Chimeras Sex
(% Pigmentation
iPS (3F) 710-8.4 G2 Terc/ 96 4–6 96 15 + 1 dead 0b
iPS (3F) 62T1-1 G3 Terc/+* 153 4–12 153 15 + 4 dead 1M (100%) 1M (70%)
1F (30%) + 3 deada
a The dead pups had pigmented eyes.
b By eye pigmentation.Cell Stem Cell 4, 141–154, February 6, 2009 ª2009 Elsevier Inc. 143
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Reprogramming of Telomere Chromatin in iPS Cellstelomeres that are not as long as the telomeres of control ES cells
in the same genetic background, upon a limited number of
passages in vitro, the iPS telomeres eventually reached full ES
telomere length (Figures 1F and 1G), in accordance with
previous findings showing that telomerase needs a number of
cell divisions in vivo in order to restore a normal average telomere
length (Siegl-Cachedenier et al., 2007). Furthermore, an
increasing number of passages of wild-type iPS cells retained
a normal telomere-capping function as indicated by normal
ploidy and a low frequency of end-to-end fusions and of
signal-free ends (Figures S4A–S4C), in agreement with the fact
that they produced mice with a high degree of chimerism and
contributed to the mouse germline (Figure S1 and Table 1).
Furthermore, telomere length in the tail skin of iPS cell-derived
mice was similar to that of age-matched, sex-matched wild-
type C57BL6 controls (Figure 1H), indicating normal telomere
dynamics in these mice. Finally, by analyzing telomere length
of single MEF and iPS cells at different passages, we observed
the appearance of iPS cells with progressively longer telomeres
compared to MEF (Figure 1I). Furthermore, the fact that, at their
time of isolation (passage 8), iPS cell clones had telomeres only
moderately longer than MEF, which are further elongated with
increasing passages, suggests that most telomere elongation
occurs postreprogramming.
Next, we addressed whether telomere elongation in iPS cells
was mediated by telomerase activity and/or by telomere-length-
ening mechanisms alternative to telomerase, which are based on
recombination between telomeric sequences (Dunham et al.,
2000) and are described to mediate telomere elongation in early
cleavage embryos (Liu et al., 2007). To this end, we measured
telomere length in iPS cells (3F) derived from G1 Terc/ MEF.
As shown both by TRF and Q-FISH techniques, telomeres
were further shortened in iPS cells derived from G1 Terc/
MEF compared to the parental wild-type MEF (Figures 1A–1E),
indicating that telomerase is the primary activity responsible
for telomere elongation in telomerase-proficient iPS cells.
Signal-free ends (chromosome ends with undetectable telomere
signals or critically short telomeres) were decreased in telome-
rase-proficient 3F and 4F iPS cells compared to parental MEF,
reaching similar levels to those of control ES cells (Figure 1D),
in agreement with re-elongation of short telomeres by telome-
rase during iPS cell generation. In contrast, this was not
observed in Terc/ iPS cells, which showed a further increase
in signal-free ends compared to the parental G1 Terc/ MEF
(Figure 1D). Finally, the fact that G1 Terc/ iPS cell telomeres
shortened compared to the parental MEF argues against telo-
mere recombination mechanisms operating to elongate telo-
meres during iPS cell nuclear reprogramming, at least in early-
generation G1 Terc/ cells. These results are in agreement
with telomere recombination operating from zygote to blastocyst
and switching to telomerase at the blastocyst stage (Liu et al.,
2007).
Impaired iPS Cell Generation from Late-Generation
Terc/ MEF with Critically Short Telomeres
To address whether telomere shortening in the absence of telo-
merase activity could eventually limit iPS cell generation, we
compared the frequencies of iPS cell generation from G1, G2,
and G3 telomerase-deficient MEF. Again, whereas G1 Terc/
MEF yielded a normal efficiency of iPS cell generation compared
to wild-type MEF, we detected a dramatic decrease in the effi-
ciency of iPS cell generation in G2 and G3 Terc/ MEF (Figures
2A and 2B), indicating that telomere shortening represents
a potent barrier against iPS cell generation in telomerase-defi-
cient cells. In addition, similarly to that previously observed for
G1 Terc/ iPS cells, G2 Terc/ iPS cells failed to generate
viable chimeric mice (Table 2). Importantly, the decreased iPS
cell generation was coincidental with shorter telomeres both as
determined by TRF (Figure 2C) and Q-FISH analysis (Figures
2D and 2E) and by an increase in signal-free ends and chromo-
some end-to-end fusions in the parental G1–G3 Terc/ MEF
compared to wild-type MEF, which was further aggravated in
the corresponding G1–G3 Terc/ iPS clones (Figures 2F and
2G). Interestingly, both when using TRF and Q-FISH analysis,
we noticed that average telomere length was not further short-
ened in G2 and G3 Terc/ iPS cell clones compared to the
parental G2-G3 MEF (Figures 2C–2E; see asterisk in
Figure 2C), suggesting the activation of telomerase-independent
telomere elongation mechanisms in some G2-G3 Terc/ iPS
cell clones (Figures 2A and 2B). Of notice, telomerase-indepen-
dent telomere elongation mechanisms typically lead to hetero-
geneous telomere length distributions, with the presence ofFigure 1. Telomerase-Dependent Telomere Elongation in Mouse iPS Cells
(A) TRF analysis. Two representative TRF gels are shown. Note the longer telomeres in wild-type 3F and 4F iPS cells compared to the parental MEF. In contrast,
G1 Terc/ iPS cells show shorter telomeres compared to parental MEF. Numbers refer to two to three independent cell cultures per cell type. MEF passage
number = 2; iPS passage number = 8.
(B) Telomere length distribution as determined by Q-FISH on metaphases. Two to three cell cultures per cell type were used for the analysis. MEF passage
number = 2; iPS passage number = 8. A Wilcoxon-Mann-Whitney rank sum test was used to calculate statistical significance of differences in telomere length.
(C) Quantification of average telomere length in kilobases. n, number of telomeres. MEF passage number = 2; iPS passage number = 8. Error bars, SD.
(D) Quantification of the percentage of signal-free ends. MEF passage number = 2; iPS passage number = 8. Error bars, SD. Statistical comparisons using
chi-square test are shown.
(E) Representative images of metaphasic chromosomes after telomere Q-FISH. Yellow, telomeres; blue, DAPI. MEF passage number = 2; iPS passage
number = 8.
(F) TRF analysis of two independent 4F iPS cell clones at the indicated passages. Right panel shows the signal distribution in each TRF lane.
(G) Telomere length distributions at different passages as determined by Q-FISH on metaphases. Telomere length of iPS cells increases with the passages,
reaching that of control ES cells. A Wilcoxon-Mann-Whitney rank sum test was used for statistical calculations.
(H) Telomere length by Q-FISH on tail skins. Samples were obtained from three iPS cell-derived mice (two from 4F-reprogrammed iPS cells and one from 3F
reprogrammed iPS cells) and three age-matched, sex-matched wild-type C57BL6 mice. The number of telomeres and nuclei analyzed are indicated. Telomere
length is shown in arbitrary fluorescence units (a.u.f.). Statistical analysis was performed using the Student’s t test.
(I) Average telomere length in kilobases of individual MEF and iPS cells as determined by Q-FISH. ‘‘1’’ and ‘‘2’’ indicate independent iPS cell clones. Each dot
represents the telomere length of a single metaphase. n, number of metaphases. p, passage number.
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in Figures 2C and 2D).
Elongation of short telomeres by telomerase in Terc-reconsti-
tuted mice is sufficient to rescue telomere dysfunction, as well as
degenerative pathologies and decreased life span associated
with telomere dysfunction in Terc/ mice (Hemann et al.,
2001; Samper et al., 2001; Siegl-Cachedenier et al., 2007).
Here, we addressed whether telomerase reintroduction into G3
Terc/ MEF by means of mouse crosses between Terc+/
mice and G2 Terc/mice was sufficient to rescue critically short
telomeres and iPS cell generation in MEF derived from the G3
Terc/+* offspring compared to the G3 Terc/* littermates. As
shown in Figures 2A and 2B, iPS cell efficiency was fully restored
to wild-type levels in G3 Terc/+* cells compared to G3 Terc/*
cells, both of which inherited short telomeres from the G2Terc/
parent. This rescue of iPS cell generation when using G3
Terc/+* MEF was concomitant with the disappearance of
critically short telomeres (signal-free ends) and with rescue
of chromosome end-to-end fusions in the G3 Terc/+* iPS
cells compared to iPS derived from G3 Terc/* littermates
(Figures 2F and 2G). Of interest, average telomere length in
G3 Terc/+* iPS cells was not fully restored to that of wild-type
iPS cells (Figures 2C–2E), in agreement with previous reports
showing that telomerase preferentially elongates the very short
telomeres (Hemann et al., 2001; Samper et al., 2001) and that
average telomere length is only recovered with time (Siegl-Cache-
denier et al., 2007). These results indicate that presence of criti-
cally short telomeres, rather than average telomere length, is the
key molecular event restricting iPS cell generation in the absence
of telomerase enzymatic activity. In accordance with this finding,
we were able to derive viable chimeric mice from G3 Terc/+* iPS
cells in contrast to G1–G3 Terc/ iPS cells (Table 2).
Telomeric Heterochromatin in iPS Cells Acquires ES
Cell Features
Epigenetic marks, such as DNA methylation of specific loci, are
properly reprogrammed during iPS cell generation, reaching
a pattern of DNA methylation similar to that shown by ES cells
(Wernig et al., 2007). DNA methylation at pericentric repeats
does not seem to undergo reprogramming for the trivial reason
that it remains unaltered in ES cells, iPS cells, and differentiated
cells (Wernig et al., 2007). Using 4F iPS, here we extend these
observations to interspersed repeats (SINE repeats) and to sub-
telomeric repeats, which are also fully methylated in these three
cell types (Figures 3A–3C). Together, these results suggest that
DNA methylation of repeated regions in the genome such as
pericentric repeats, SINE elements, and subtelomeric repeats
does not significantly vary during nuclear reprogramming. In
contrast, we observed a decrease in the density of H3K9m3
and H4K20m3 histone heterochromatic marks at the telomeres
of iPS cells (passage 8) and ES cells compared to differentiated
MEFs (Figure 4A). A similar decrease in these marks was also
observed at pericentric repeats (Figure 4B). Importantly, this
decrease in heterochromatic marks cannot be attributed to
differences in the input of telomeric or pericentric DNA or in
nucleosome density at these regions, as ChIP values were cor-
rected both by telomere and centromere inputs, respectively,
as well as by H3 and H4 abundance at these domains (Figures
4A and 4B). Of notice, we did not detect significant changes in
the density of the TRF1 shelterin protein at telomeres between
iPS cells, ES cells, and MEF (Figure 4A). As control, TRF1 was
not detected at pericentric chromatin (Figure 4B).
We have previously described that heterochromatic marks at
telomeres repress homologous recombination events between
telomeric repeats (Gonzalo et al., 2006; Benetti et al., 2007).
Next, we determined telomere recombination frequencies in
ES cells, iPS cells, and parental MEF by using chromosome
orientation-FISH (CO-FISH) (Experimental Procedures), which
measures frequency of chromatid exchanges between sister
telomeres (T-SCEs). Interestingly, iPS cells (passage 8) showed
higher telomere recombination frequencies than parental MEF,
reaching similar values to those of ES cells (Figure S5). Together,
these results suggest that telomere chromatin adopts a less-
compacted conformation in ES cells compared to differentiated
cells and that telomeric chromatin in iPS cells resembles that of
control ES cells.
Increased Telomere Transcription in iPS Cells
Telomere chromatin is transcribed, generating long noncoding
UUAGGG-rich transcripts (TelRNAs or TERRAs) that remain
associated to the telomeric chromatin (Azzalin et al., 2007;
Schoeftner and Blasco, 2008), where they have been proposed
to act as negative regulators of telomere length (Schoeftner
and Blasco, 2008). In particular, abundance of TelRNAs is posi-
tively correlated with telomere length, and these RNAs can effi-
ciently inhibit telomerase activity in in vitro TRAP assays
(Schoeftner and Blasco, 2008). In agreement with their longer
telomeres, we find that TelRNAs are more abundant in ES cellsFigure 2. Impaired iPS Cell Generation from Late Generation Terc/ MEF with Critically Short Telomeres
(A) Quantification of relative efficiency of iPS cell clone generation. Values are normalized to viral transduction efficiency (EGFP fluorescence). Efficiency of iPS cell
generation is decreased in G2 and G3 Terc/ MEF but is fully restored upon telomerase reintroduction into G3 Terc/ MEF (G3 Terc/+* cells). Error bars, SE.
Statistical analysis was performed using a Student’s t test. n, number of independent measurements.
(B) Representative images of alkaline phosphatase-positive iPS cell clones.
(C) Telomere length analysis by TRF. Note that a subset of the telomeres is elongated in G2 and G3 Terc/ iPS cell clones compared to the parental G2-G3 MEF
(asterisk). MEF passage number = 2; iPS passage number = 8.
(D) Telomere length as determined by Q-FISH on metaphase spreads. Statistical significance values are shown as assessed by the Wilcoxon-Mann-Whitney rank
sum test. MEF passage number = 2; iPS passage number = 8.
(E) Quantification of average telomere length in kilobases. n, number of telomeres analyzed. MEF passage number = 2; iPS passage number = 8. Error bars, SD.
(F) Quantification of the percentage of signal-free ends. MEF passage number = 2; iPS passage number = 8. Note the disappearance of signal-free ends in the G3
Terc/+* iPS compared to the parental G3 Terc/+* MEF. n, number of telomeres. Statistical comparisons using the chi-square test are shown.
(G) Frequency of end-to-end chromosome fusions. n, number of metaphases. The total number of fusions out of the number of chromosomes analyzed is also
indicated. MEF passage number = 2; iPS passage number = 8. Chi-square test was used for statistical analysis. Error bars, SE.
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Reprogramming of Telomere Chromatin in iPS Cellsthan in differentiated MEF, whereas iPS (4F) (passage 8) show
intermediate levels (Figures 4C and 4D), probably because addi-
tional rounds of cell division are needed to reach full telomere
elongation by telomerase (Figures 1F and 1G). Intriguingly,
production of centromeric transcripts was lower in ES cells
compared to parental MEF, and a similar scenario was found
for iPS cells (Figure 4C), pinpointing fundamental differences in
the regulation of telomeric and centromeric transcription. In
summary, these results indicate that iPS cell telomeres show
higher transcriptional levels than differentiated cells, in agree-
ment with their decreased density of histone heterochromatic
marks (Figure 4A).
Telomere Elongation in iPS Cells Derived from Old
Donors
Telomeres shorten with aging, and this telomere shortening is
known to limit the proliferative capacity of stem cells. There is,
therefore, an interesting question of whether telomere length of
donor cells represents a potential barrier to the proper function-
ality of iPS cells and whether iPS cells derived from donors with
a limited telomere reserve, such as elderly individuals or patients
with diseases characterized by short telomeres, would inherit
telomeric defects, including suboptimal telomere length. To
address this question, we generated iPS cells from dermal skin
fibroblast obtained from young (22 weeks old) and old (121
weeks old) mice (Figure 5). Dermal fibroblasts derived from old
donors showed shorter telomeres than those of young dermal
fibroblasts both when determined by TRF (Figure 5A) and by
Q-FISH (Figures 5B and 5C), in agreement with telomere short-
ening with mouse aging (Flores et al., 2008). Importantly, telo-
meres of iPS cells from old donors were elongated similarly to
those of iPS cells from young donors as indicated by TRF
(Figure 5A) and Q-FISH (Figures 5B and 5C). The percentage
of signal-free ends and the frequency of end-to-end fusions
were also similarly low in iPS cells derived from young and old
dermal fibroblasts (Figures 5D and 5E), suggesting normal telo-
mere functionality in these cells.
DISCUSSION
We show here that mouse iPS cell telomeres adopt similar
features to those of ES cell telomeres. In particular, telomere
length was significantly increased in 3F and 4F iPS cells
compared to parental differentiated cells, reaching intermediate
levels to those of control ES cells in early passages but reaching
telomere length comparable to control ES cells at later
passages. We interpret that reprogramming changes the acces-
sibility of telomerase to telomeres, allowing their progressive
elongation until telomeres reach the length characteristic of ES
cells.
A similar scenario is found for the generation of telomere
RNAs, in agreement with the abundance of telomere transcripts
being directly correlated with telomere length (Schoeftner and
Blasco, 2008). In addition, telomere heterochromatin is remod-
eled in iPS cells to a similar conformation as that shown by ES
cells’ telomeric chromatin. In particular, both iPS and ES cells
show a significant decrease in the density of histone heterochro-
matic marks (H3K9m3 and H4K30m3) at telomeric regions
compared to differentiated MEF cells and present higher telo-
mere recombination frequencies than parental MEF cells, sug-
gesting a more relaxed chromatin conformation associated to
pluripotent stem cells, in agreement with their higher transcrip-
tional activity. These results go in line with the recent findings,
suggesting a higher plasticity in the chromatin of pluripotent
embryonic stem cells compared to differentiated cells (Meshorer
et al., 2006).
Importantly, we show that donor cells with short telomeres ob-
tained from old animals show telomere elongation and functional
telomere capping during reprogramming into iPS cells, predict-
ing full functionality and long-term regenerative potential of iPS
derived from individuals with a limited telomere reserve, such
as elderly individuals or patients suffering from diseases charac-
terized by short telomeres (Blasco, 2005). However, these
results also raise the potential problem of a less efficient reprog-
ramming of iPS cells derived from patients with germline telome-
rase mutations, such as dyskeratosis congenita and some cases
of aplastic anemia and idiopathic pulmonary fibrosis, as telo-
mere elongation during iPS cell generation requires an active
telomerase complex. This is supported by our findings showing
that MEF derived from increasing generations of Terc-deficient
mice have a decreased iPS cell efficiency from the second
generation onward, which is concomitant with the presence of
short telomeres and increased chromosomal aberrations. This
parallels the decreased stem cell functionality of different adult
stem cell compartments of telomerase-deficient mice, including
neural stem cells, epidermal stem cells, and hematopoietic stem
cells (Samper et al., 2002; Allsopp et al., 2003; Ferro´n et al., 2004;
Flores et al., 2005). Importantly, the fact that telomerase reintro-
duction and re-elongation of short telomeres are sufficient to
restore a normal iPS cell generation and iPS cell functionality,
as determined by generation of viable chimeras in late-genera-
tion telomerase-deficient MEF, pinpoints to telomerase reactiva-
tion as a putative therapeutic strategy to derive functional iPS
cells from patients harboring telomerase mutations and a limited
telomere reserve.
EXPERIMENTAL PROCEDURES
Generation of Mouse iPS Cells
Reprogramming of primary (passage 2–4) MEF derived either from wild-type or
different generation (G1–G3) telomerase null Terc/ embryos (MEFs of
C57BL6 genetic background) or skin fibroblasts derived from young and old
animals was performed essentially as described (Blelloch et al., 2007). Briefly,
retroviral supernatants were produced in HEK293T cells (5 3 106 cells per
100 mm diameter dish) transfected with the ecotropic packaging plasmid
pCL-Eco (4 mg) together with either one of the following retroviral constructs
(4 mg): pMXs-cMyc, pMXs-Klf4, pMXs-Sox2, or pMXs-Oct3/4 (Addgene).
Transfections were performed using Fugene-6 transfection reagent (Roche)
according to the manufacturer’s protocol. At 2 days later, retroviral superna-
tants (10 ml) were collected serially during the subsequent 48 hr at 12 hr
(B and C) Abundance of methylated CpG dinucleotides as determined by bisulfite sequencing in the indicated subtelomeric regions. n = 17–55 clones were
analyzed from a total of two cultures per cell type. Yellow and blue represent the frequency of methylated and unmethylated CpG dinucleotides, respectively.
Gray corresponds to undetermined methylation. CpG, CpG position; U, unmethylated; M, methylated; n.p., not present. Chi-square test was used for statistical
analysis, and the significant differences are indicated. Error bars, SD. MEF passage number = 2; iPS passage number = 8.
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Reprogramming of Telomere Chromatin in iPS Cellsintervals, each time adding fresh medium to the cells (10 ml). The recipient MEF
had been seeded the previous day (1–3 3 105 cells per 60 mm diameter dish)
and received 1 ml of each of the corresponding retroviral supernatants (either
a total of three or four). This procedure was repeated every 12 hr for 2 days
(a total of four additions). After infection was completed, media was replaced
with standard ES media supplemented with knockout serum replacement
(KSR, Invitrogen). Cultures were maintained in the absence of drug selection
(Blelloch et al., 2007) with daily medium changes. As early as 10 days after,
colonies with ES-like morphology became visible at the microscope. Colonies
were picked after 2–3 weeks and were expanded on feeder fibroblasts using
standard procedures. For quantification of iPS generation efficiency, retroviral
transduction was measured in parallel infections with three or four factors, as it
applies, plus a GFP retroviral plasmid, followed by FACS analysis 2 days after
infection was completed. The total number of iPS colonies was counted after
staining plates for alkaline phosphatase activity (AP detection kit, Chemicon
International) following the manufacturer’s instruction.
The capacity of the iPS clones to generate chimeras in vivo was tested by
microinjection into C57BL/6J-Tyr(C-2J)/J (albino) blastocysts (see Figure S1D)
or by aggregation with CD1 (albino) morulae following standard procedures.
So far, three independent wild-type iPS clones have been tested, two of
them obtained by expression of four factors and one by expression of three
factors. In all three cases, around 30% of the pups born were chimeras as
judged by the coat color, with iPS contribution to the coat in a range of
60%–100% in the case of microinjected blastocysts and 30%–50% in the
case of aggregation to morulae.
TRF Analysis
Cells were included in agarose plugs, and TRF analysis was performed as
described previously (Blasco et al., 1997).
Q-FISH Analysis
We prepared metaphases and performed Q-FISH hybridization as previously
described (Samper et al., 2001; Gonzalo et al., 2006). TFL-Telo software (Zijl-
mans et al., 1997) was used to quantify the fluorescence intensity of telomeres
from at least five to ten metaphases for each data point.
Q-FISH comparing in vivo telomere length of iPS-derived mice was per-
formed in tail skin sections as described (Mun˜oz et al., 2005). The telomere
length in epidermal cells from iPS cell-derived chimeric mice was compared
to that from tail skin derived from age-matched, sex-matched C57BL/6
controls obtained by standard breeding procedures. Telomere fluorescence
intensity in 37 nuclei from each mouse was analyzed using the TFL-Telo soft-
ware. Statistical analysis was performed using unpaired Student’s t test
comparing average fluorescence intensity in each mouse.
B1-SINE Cobra Analysis for Global DNA Methylation
Global DNA methylation levels were determined using the B1-SINE Cobra
method as previously described (Benetti et al., 2007). Estimation of the fraction
of methylated B1 elements for each genotype was done using the formula:
((molarity of 45 bp band) / 2)/((molarity of 45 bp band) + (molarity of 100 bp
band)).
Analysis of Genomic Subtelomeric DNA Methylation
DNA methylation of subtelomeric genomic regions of the chromosome 1 and
chromosome 2 (q arms) was established by PCR analysis after bisulfite modi-
fication as described (Benetti et al., 2007).
ChIP Assay
ChIP assays were performed as previously described (Garcı´a-Cao et al., 2004)
with the following antibodies: 6 ug of anti-histone H3 (# ab1791, Abcam), 6 mg
of anti-histone H4 (# ab10158, Abcam), 6 mg of anti-H3K9me3 (#07-442,
Upstate Biotechnology), 6 mg of anti-H4K20me3 (# 07-749, Upstate Biotech-
nology), 8 ml of rabbit polyclonal antibody to TRF1 (raised in our laboratory
against full-length mouse TRF1 protein), 10 ml of monoclonal anti-HP-1g
(# 05-690, Upstate Biotechnology), or preimmune serum. The amount of telo-
meric and pericentric DNA after ChIP was normalized to the total telomeric or
centromeric DNA signal, respectively, for each genotype, as well as to the H3
and H4 abundance at these domains, thus correcting for differences in the
number of telomere repeats.
Telomere Transcription
Abundance of telomeric as centromeric transcripts was determined as previ-
ously described (Schoeftner and Blasco, 2008).
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures and
five figures and can be found with this article online at http://www.cell.com/
cell-stem-cell/supplemental/S1934-5909(09)00002-2.
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